New patent for Biocryst drug ORLADEYO

Annual Drug Patent Expirations for ORLADEYO Orladeyo is a drug marketed by Biocryst and is included in one NDA. There are five patents protecting this drug. This drug has forty-eight…
The post New patent for Biocryst drug ORLADEYO appeared first on Dru…


Which pharmaceutical companies have the most drug patents in Cyprus?

This chart shows the pharmaceutical companies with the most patents in Cyprus. Patents must be filed in each country (or, in some cases regional patent office) where patent protection is…
The post Which pharmaceutical companies have the most drug paten…


Biotechblog